Showing results (2241-2250 of 2,750) with videos related to

Sort By:
Pageof 275
Clinical and Experimental Nephrology|October 31, 2003
Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction dietEnyu Imai, Masaru Takenaka, Yoshitaka Isaka, et al.
Clinical and Experimental Nephrology|October 31, 2003
Treatment of diabetic nephropathy with angiotensin II receptor antagonistEdmund J Lewis, Julia B Lewis
Clinical and Experimental Nephrology|October 31, 2003
Molecular pathogenesis of nephrogenic diabetes insipidusMinhtri K Nguyen, Søren Nielsen, Ira Kurtz
Clinical and Experimental Nephrology|October 31, 2003
Mitochondrial DNA deletion of proximal tubules is the result of itai-itai diseaseShigeo Takebayashi, Shiro Jimi, Masaru Segawa, et al.
Clinical and Experimental Nephrology|October 31, 2003
Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)gamma activatorsKazutaka Haraguchi, Hiroki Shimura, Toshimasa Onaya
Clinical and Experimental Nephrology|October 31, 2003
Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatmentHisashi Makino, Masashi Mukoyama, Akira Sugawara, et al.
Clinical and Experimental Nephrology|October 31, 2003
Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartanKouichi Tamura, Masanari Umemura, Hideto Yano, et al.
Clinical and Experimental Nephrology|October 31, 2003
Cystic renal cell carcinoma, suspected because of lack of regression of renal cysts after renal transplantation in a dialysis patient with acquired renal cystic diseaseIsao Ishikawa, Atsushi Saito, Yoshihiro Chikazawa, et al.
Clinical and Experimental Nephrology|July 6, 2004
Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-type amyloidosisYutaka Osawa, Kazuko Kawamura, Daisuke Kondo, et al.
Clinical and Experimental Nephrology|July 6, 2004
Suppression of parathyroid hormone secretion in CAPD patients by intraperitoneal administration of MaxacalcitolKazutaka Murakami, Hiromi Miyachi, Asako Watanabe, et al.
Pageof 275